Ebv Epstein Barr Virus | List of Frontiers open access articles

Case Report

Published on 28 Jan 2025

The probable progression of Epstein-Barr virus (EBV) to chronic active EBV/reactivation weakens the immune response and stimulates Cryptococcus neoformans infection, which invariably proves fatal: a case report and review of the literature

in Viral Disease Investigation

Gargee Mishra
Gaurav Sarnaik
Joydeep Samanta
Archana Keche
Sanjay Singh Negi

Frontiers in Virology

doi 10.3389/fviro.2024.1485608

7,741 views
1 citation

Review

Published on 25 Feb 2019

Progress in EBV Vaccines

in Hematologic Malignancies

Dwain G. van Zyl
Josef Mautner
Henri-Jacques Delecluse

Frontiers in Oncology

doi 10.3389/fonc.2019.00104

20,262 views
79 citations

Review

Published on 15 Mar 2019

Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders

in Hematologic Malignancies

James P. Dugan
Carrie B. Coleman
Bradley Haverkos

Frontiers in Oncology

doi 10.3389/fonc.2019.00127

22,331 views
44 citations

Case Report

Published on 16 Oct 2018

EBV Negative Lymphoma and Autoimmune Lymphoproliferative Syndrome Like Phenotype Extend the Clinical Spectrum of Primary Immunodeficiency Caused by STK4 Deficiency

in Primary Immunodeficiencies

Cyrill Schipp
David Schlütermann
Andrea Hönscheid
Schafiq Nabhani
Jessica Höll
Prasad T. Oommen
Sebastian Ginzel
Bernhard Fleckenstein
Björn Stork
Arndt Borkhardt

Frontiers in Immunology

doi 10.3389/fimmu.2018.02400

7,863 views
49 citations

Review

Published on 12 Dec 2018

Current Understanding and Future Research Priorities in Malignancy Associated With Inborn Errors of Immunity and DNA Repair Disorders: The Perspective of an Interdisciplinary Working Group

in Primary Immunodeficiencies

Simon Bomken
Jutte van der Werff Ten Bosch
Andishe Attarbaschi
Chris M. Bacon
Arndt Borkhardt
Kaan Boztug
Ute Fischer
Fabian Hauck
Roland P. Kuiper
Tim Lammens

Frontiers in Immunology

doi 10.3389/fimmu.2018.02912

8,997 views
66 citations

Review

Published on 15 Mar 2019

Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases

in Pediatric Immunology

Wook Youn Kim
Ivonne A. Montes-Mojarro
Falko Fend
Leticia Quintanilla-Martinez

Frontiers in Pediatrics

doi 10.3389/fped.2019.00071

34,874 views
137 citations

Hypothesis and Theory

Published on 21 May 2020

Arguments to Support a Viral Origin of Oral Squamous Cell Carcinoma in Non-Smoker and Non-Drinker Patients

in Head and Neck Cancer

Jean-Philippe Foy
Chloé Bertolus
David Boutolleau
Henri Agut
Antoine Gessain
Zdenko Herceg
Pierre Saintigny

Frontiers in Oncology

doi 10.3389/fonc.2020.00822

7,505 views
29 citations

Articles

The probable progression of Epstein-Barr virus (EBV) to chronic active EBV/reactivation weakens the immune response and stimulates Cryptococcus neoformans infection, which invariably proves fatal: a case report and review of the literature

Progress in EBV Vaccines

Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders

EBV Negative Lymphoma and Autoimmune Lymphoproliferative Syndrome Like Phenotype Extend the Clinical Spectrum of Primary Immunodeficiency Caused by STK4 Deficiency

Current Understanding and Future Research Priorities in Malignancy Associated With Inborn Errors of Immunity and DNA Repair Disorders: The Perspective of an Interdisciplinary Working Group

Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases

Arguments to Support a Viral Origin of Oral Squamous Cell Carcinoma in Non-Smoker and Non-Drinker Patients